Search
Back

Site Inspections

Site Inspections
Date MOH Site Status
2024 Aug 5 MOH SÚKL (State institute of drug control) Site Teva api Czech, Opava Status Acceptable
Mar 15 MOH Local MOH Site Teva api India, Gajraula Status Acceptable
Jan 2 MOH ANVISA Site Teva api Hungary Status Acceptable
2023 Dec 20 MOH AIFA Site Teva api Italy, Rho Status Acceptable
Dec 2 MOH ANVISA Site Teva api Italy, Rho Status Acceptable
Nov 15 MOH ANVISA Site Teva api Croatia, Zagred Status Acceptable
Mar 30 MOH PMDA Site Teva api Mexico Status Acceptable
Jan 23 MOH AIFA Site Teva api Italy, Rho Status Acceptable
2022 Aug 5 MOH AIFA Site Teva api Italy, Villanterio Status Acceptable
Jun 7 MOH Indian FDA Site Teva api India, Malanpur Status Acceptable
Apr 15 MOH AIFA Site Teva api Italy, Santhia Status Acceptable
Apr 8 MOH CDSCO Site Teva api India, Gajraula Status Acceptable
Mar 31 MOH Local MOH Site Teva api Croatia Status Acceptable
Mar 25 MOH Local MOH Site Teva api Hungary Status Acceptable
Jan 9 MOH USFDA Site Teva api India, Gajraula Status Acceptable
2021 Nov 16 MOH UP State FDA Site Teva api India, Gajraula Status Acceptable
Jul 20 MOH SUKL Site Teva api Czech Status Acceptable
Jun 22-23 MOH Local MOH Site Teva api India Malanpur Status Acceptable
Jan 4 MOH Local MOH Site Teva api IL, Plantex Status Acceptable
2020 Feb 17-21 MOH AIFA Site Teva api Italy, Rho Status Acceptable
Feb 11-14 MOH PMDA Site Teva api India, Malanpur Status Acceptable
Jan 20-24 MOH USFDA Site Teva api Croatia Status Acceptable
Jan 13-17 MOH USFDA Site Teva api India, Gajraula Status Acceptable
2019 Dec 26 MOH Indian FDA / MOH Site Teva api India, Gajraula Status Acceptable
Dec 9-13 MOH UDFDA Site Teva api Mexico Status Acceptable
Dec 1-4 MOH IL MOH Site Teva api IL, Teva Tech Status Acceptable
Nov 26 MOH CFDA Site Teva api China Status Acceptable
Nov 25-28 MOH EDQM / EMA (Joint Ins.) Site Teva api India, Ambernath Status Acceptable
Nov 10-14 MOH USFDA Site Teva api IL, Plantex Status Acceptable
Oct 24 MOH Indian FDA / MOH Site Teva api India, Ambernath Status Acceptable
Sep 9-12 MOH AIFA Site Teva api Italy, Caronno Status Acceptable
Sep 8-12 MOH USFDA Site Teva api IL, Teva Tech Status Acceptable
Aug 28-30 MOH CFDA Site Teva api China Status Acceptable
Jul 29 - Aug 2 MOH EMA Site Teva api China Status Acceptable
Jul 22-26 MOH AIFA Site Teva api Italy, Bulciago Status Acceptable
Jul 2-3 MOH SÚKL (State institute of drug control) Site Teva api Czech Status Acceptable
Jul 1-2 MOH Indian FDA / MOH Site Teva api India, Ambernath Status Acceptable
Jun 17-18 MOH Indian FDA / MOH Site Teva api India, Gajraula Status Acceptable
Jun 11-14 MOH PMDA Site Teva api India, Gajraula Status Acceptable
May 6-10 MOH Croatia MOH Site Teva api Croatia Status Acceptable
Apr 9-10 MOH Indian FDA / MOH Site Teva api India, Malanpur Status Acceptable
Apr 8-16 MOH USFDA Site Teva api India, Malanpur Status Acceptable
Apr 8-12 MOH AIFA Site Teva api Italy, Bulciago Status Acceptable
Mar 30 MOH Indian FDA / MOH Site Teva api India, Ambernath Status Acceptable
Mar 18 MOH Indian FDA / MOH Site Teva api India, Ambernath Status Acceptable
Feb 28 - Mar 21 MOH Indian FDA / MOH Site Teva api India, Gajraula Status Acceptable
Feb 18-21 MOH AIFA Site Teva api Italy, Villanterio Status Acceptable
Feb 9 MOH Indian FDA / MOH Site Teva api India, Malanpur Status Acceptable
Feb 6 MOH ISO Site Teva api IL, Plantex Status Acceptable
Feb 3 MOH ISO Site Teva api IL, Teva Tech Status Acceptable
Jan 21-25 MOH OGYEI Site Teav api Hungary Status Acceptable
Jan 14-15 MOH Russian MOH Site Teva api IL, Teva Tech Status Acceptable
2018 Dec 28 - Jan 14 MOH MHRA (UK) Site Coleraine Status Acceptable
Dec 17-21 MOH AIFA Site Teva api Italy, Santhia Status Acceptable
Nov 26-29 MOH Czech MOH Site Teva api Czech Status Acceptable
Nov 9 MOH Instituto Superiore Site Teva api Italy, Rho Status Acceptable
Oct 11-12 MOH CFDA Site Teva api China Status Acceptable
Sep 17-21 MOH AIFA Site Teva api Italy, Bulciago Status Acceptable
Sep 17-21 MOH FDA Site Teva api Italy, Bulciago Status Acceptable
Aug 6-10 MOH FDA Site Teva api India, Ambernath Status Acceptable
Jul 9-12 MOH AIFA Site Teva api Italy, Rho Status Acceptable
Jun 27 MOH CFDA Site Teva api China Status Acceptable
Jun 6-7 MOH India MOH Site Teva api India, Malanpur Status Acceptable
Jun 4-8 MOH FDA Site Teva api Mexico Status Acceptable
May 21-25 MOH FDA Site Teva api Italy, Rho Status Acceptable
May 8-11 MOH OGYEI (HU MOH) Site Teva api Hungary Status Acceptable
May 7-11 MOH FDA Site Lithuania (Biotech) Status Acceptable
Apr 10-13 MOH PMDA Site Teva api Hungary Status Acceptable
Apr 9-13 MOH COFEPRIS Site Teva api Mexico Status Acceptable
Mar 19 MOH India MOH Site Teva api India, Ambernath Status Acceptable
Mar 12-15 MOH FDA Site Teva api India,Malanpur Status Acceptable
Feb 20-23 MOH AIFA Site Teva api Italy, Rho Status Acceptable
Feb 11-14 MOH IL MOH Site Teva api IL, Plantex Status Acceptable
Feb 5-9 MOH FDA Site Teva api India, Gajraula Status Acceptable
Jan 29 - Feb 2 MOH FDA Site Teva api China Status Acceptable
Jan 28 MOH ISO Site Teva api IL, Plantex Status Acceptable
Jan 24 MOH ISO Site Teva api IL, Teva Tech Status Acceptable
Jan 18 MOH India MOH Site Teva api India, Gajraula Status Acceptable
2017 Nov 21-22 MOH OGYEI (HU MOH) Site Teva api Hungary, Sajobabony Status Acceptable
Nov 12-16 MOH Russian MOH Site Teva api IL, Teva Tech Status Acceptable
Oct 24-26 MOH EDQM Site Teva api India, Ambernath Status Acceptable
Sep 13-15 MOH EDQM Site Teva api China Status Acceptable
Sep 11-15 MOH FDA Site Teva api Italy, Santhia Status Acceptable
Sep 7-9 MOH Russian MOH Site Teva api India, Malanpur Status Acceptable
Sep 4-6 MOH Russian MOH Site Teva api Mexico Status Acceptable
Aug 28-31 MOH Russian MOH Site Teva api India, Gajraula Status Acceptable
Aug 19-20 MOH CFDA Site Teva api China Status Acceptable
Jul 24-29 MOH Russian MOH Site Teva api Italy, Bulciago Status Acceptable
Jul 5 MOH WHO Site Teva api India, Gajraula Status Acceptable
May 29-31 MOH MFDS KOREA Site Teva api Czech Status Acceptable
May 15-18 MOH HALMED (Croatian MOH) Site Teva api Croatia (SM; PbF) Status Acceptable
Apr 17 MOH Maharashtra FDA (India MOH) Site Teva api India, Ambernath Status Acceptable
Apr 3-7 MOH Russian MOH Site Teva api Croatia Status Acceptable
Mar 20-24 MOH FDA Site Teva api Czech Status Acceptable
Mar 13-17 MOH FDA Site Teva api Croatia Status Acceptable
Mar 6-10 MOH FDA Site Teva api Hungary, Debrecen Status Acceptable
Mar MOH OGYEI (HU MOH) Site Teva api Hungary, Sajobabony Status Acceptable
Feb 20-24 MOH COFEPRIS Site Teva api Mexico Status Acceptable
Feb 5-9 MOH FDA Site Teva api IL, Plantex Status Acceptable
Jan 23-26 MOH IL MOH Site Teva api IL, Teva Tech Status Acceptable
Jan 11-13 MOH French MOH Site Teva api India, Gajraula Status Acceptable